Visiting Speakers Program in Oncology
The Visiting Speakers Program in Oncology (VSPO) based at the Gerald Bronfman Centre, is a joint program between McGill University and the Université de Montréal, which sponsors internationally-renowned oncology specialists to come share their expertise with the medical community of Montreal.
In a mutual effort to expand and enhance this academic program, we planned to have thirteen invited Professors over the 2015-2016 period, who will give two to three lectures at the various hospitals and institutes affiliated with McGill University and the Université de Montréal. The guest speakers will be proposed in an effort to cover as many different fields related to oncology as possible. Therefore a varied array of tumour sites and specialties of interest will be represented. In this regard, medical as well as non-medical professional subjects will be proposed. Potential candidates are subject to review by the medical executive committee of the VSPO. Further analyses of education needs will be solicited by subject specialists from McGill and Université de Montréal in order to identify a host for the invited professor and to guide the executive committee on the conference objectives.
Information about the Continuing Professional Development
This event is approved for up to 1 credit by the Continuing Professional Development (CPD) Office. The CPD Office of the Faculty of Medicine, McGill University is fully accredited by the Committee on Accreditation of Canadian Medical Education (CACME). This event is an Accredited Group Learning Activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credits to AMA credits can be found here. Each physician should claim only credits commensurate with the extent of their participation in the activity.
514-934-1934 X 43118
514-890-8000 X 25381
This program has received an educational grant from: Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eisai, Gilead, Janssen, Lilly Oncology, Lundbeck, Merck, Novartis, Pfizer, Roche